Increased risk of testicular germ cell cancer among infertile men

Archives of Internal Medicine

Volumn 169, Issue 4, 2009, Pages 351-356

  Walsh, Thomas J ^a,b   Croughan, Mary S ^a   Schembri, Michael ^a   Chan, June M ^a   Turek, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; GERM CELL TUMOR; HAZARD RATIO; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MULTIVARIATE ANALYSIS; POPULATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TIME SERIES ANALYSIS;

ADULT; CALIFORNIA; GERMINOMA; HUMANS; INFERTILITY, MALE; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 61449110204     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2008.562     Document Type: Article

References (23)

1. Surveillance Epidemiology and End Results (SEER) Program Web site. http://seer.cancer.gov/faststats/selections.php. Accessed October 1, 2007.
2. Jacobsen R, Møller H, Thoresen SO, Pukkala E, Kjær SK, Johansen C. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl. 2006;29(1):199-204.
3. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med. 1995;332(5):281-285.
4. Carlsen E, Giwercman A, Keiding N, Skakkebæk NE. Evidence for decreasing quality of semen during past 50 years. BMJ. 1992;305(6854):609-613.
5. Doria-Rose VP, Biggs ML, Weiss NS. Subfertility and the risk of testicular germ cell tumors (United States). Cancer Causes Control. 2005;16(6):651-656.
6. Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol. 2005;174(5):1819-1822.
7. Jacobsen R, Bostofte E, Engholm G, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ. 2000;321(7264):789-792.
8. Møller H, Skakkebæk NE. Risk of testicular cancer in subfertile men: case- control study. BMJ. 1999;318(7183):559-562.
9. Forman D, Pike MC, Davey G, et al; United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. BMJ. 1994;308(6941):1393-1399.
10. Swerdlow AJ, Huttly SR, Smith PG. Testis cancer: post-natal hormonal factors, sexual behaviour and fertility. Int J Cancer. 1989;43(4):549-553.
11. Richiardi L, Akre O, Montgomery SM, Lambe M, Kvist U, Ekbom A. Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J Natl Cancer Inst. 2004;96(2):145-147.
12. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. Cambridge, England: Cambridge University Press; 1999.
13. Richie JP, Steele GS. Neoplasms of the testis. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, PA: Saunders Elsevier; 2007:902-903.
14. Germà-Lluch JR, Garcia del Muro X, Maroto P, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol. 2002;42(6):553-563.
15. Pukkala E, Weiderpass E. Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971-95. Int J Cancer. 2002;102(6):643-648.
16. Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol. 2007;178(4, pt1):1440-1446.
17. Jain T, Gupta RS. Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med. 2007;357(3):251-257.
18. Maduro MR, Casella R, Kim E, et al. Microsatellite instability and defects in mismatch repair proteins: a new aetiology for Sertoli cell-only syndrome. Mol Hum Reprod. 2003;9(2):61-68.
19. Nudell D, Castillo M, Turek PJ, Pera RR. Increased frequency of mutations in DNA from infertile men with meiotic arrest. Hum Reprod. 2000;15(6):1289-1294.
20. Baker SM, Plug AW, Prolla TA, et al. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet. 1996;13(3):336-342.
21. de Wind N, Dekker M, Berns A, Radman M, te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyper-recombination, and predisposition to cancer. Cell. 1995;82(2):321-330.
22. Jass JR, Cottier DS, Jeevaratnam P, et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet. 1995;346(8984):1200-1201.
23. Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16(5):972-978.